Keyphrases
Anemia
22%
Boceprevir
24%
Chronic Hepatitis B
79%
Chronic Hepatitis C
47%
Clinical Outcomes
23%
COVID-19
70%
Daclatasvir
29%
Direct-acting Antivirals
24%
Entecavir
49%
Gene Polymorphism
22%
Genotype
38%
Genotype E
38%
GS-331007
21%
HBeAg-negative
22%
Hepatitis B e Antigen (HBeAg)
19%
Hepatitis B Surface Antigen (HBsAg)
23%
Hepatitis C Virus
43%
Hepatitis C Virus Genotypes
18%
High Performance Liquid Chromatography-tandem Mass Spectrometry (HPLC-MS/MS)
36%
Hospitalized Patients
42%
IL28B
34%
Interferon-free Therapy
20%
Interferon-α (IFN-α)
21%
Italy
34%
Mixed Cryoglobulinemia
28%
MS Method
35%
Multivariate Analysis
20%
Nave
42%
Odds Ratio
17%
Pathway Genes
25%
Peginterferon
21%
Pegylated Interferon
59%
Peripheral Blood Mononuclear Cells
36%
Pharmacogenetics
44%
Plasma Concentration
60%
Plasma Parameters
17%
Polymorphism
23%
Retrospective Analysis
37%
Ribavirin
100%
Rs12979860
21%
Rs8099917
23%
SARS-CoV-2 Infection
21%
SNP
18%
Sofosbuvir
38%
Sustained Virological Response
28%
Telaprevir
39%
Tenofovir
21%
Triple Therapy
22%
Virological Response
32%
Vitamin D Pathway
33%
Pharmacology, Toxicology and Pharmaceutical Science
Adult Respiratory Distress Syndrome
11%
Adverse Event
13%
Anemia
17%
Antiviral Drug
18%
Boceprevir
24%
Chronic Hepatitis B
78%
Chronic Hepatitis C
42%
Coronavirinae
41%
Cryoglobulinemia
16%
Daclatasvir
30%
Dasabuvir
16%
Diseases
53%
Entecavir
49%
Fibrosis
13%
Hepatitis B
17%
Hepatitis B Antigen
35%
Hepatitis B Virus
76%
Hepatitis B(e) Antigen
37%
Hepatitis C
18%
Hepatitis C Virus
26%
Hepatitis C Virus Genotype 1
27%
Hospital Mortality
16%
Infection
53%
Interferon
38%
Liver Cirrhosis
16%
Ombitasvir
16%
Paritaprevir
16%
Peginterferon
54%
Peginterferon Alpha
14%
Pharmacogenetics
39%
Pharmacokinetics
29%
Polyethylene Glycol
17%
Prevalence
16%
Prospective Study
17%
Proteinase Inhibitor
16%
Remdesivir
11%
Ribavirin
91%
Ritonavir
16%
SARS Coronavirus
15%
Side Effect
10%
Simeprevir
11%
Sofosbuvir
35%
Syndrome
16%
Telaprevir
39%
Telbivudine
14%
Tenofovir
21%
Tenofovir Disoproxil
12%
Ultra High Performance Liquid Chromatography
13%
Virus DNA
12%
Vitamin D
33%